NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+20.86%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.21B
AUM Growth
+$2.21B
Cap. Flow
-$73.6M
Cap. Flow %
-3.33%
Top 10 Hldgs %
77.25%
Holding
38
New
3
Increased
1
Reduced
2
Closed
2

Sector Composition

1 Healthcare 62.5%
2 Communication Services 14.94%
3 Technology 9.43%
4 Consumer Discretionary 1.12%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RIGL icon
26
Rigel Pharmaceuticals
RIGL
$710M
$11.6M 0.52%
324,315
VIRX
27
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$11.4M 0.52%
22,187
AUPH icon
28
Aurinia Pharmaceuticals
AUPH
$1.58B
$11.1M 0.5%
2,546,843
ROKA
29
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$10.3M 0.47%
322,043
DZSI
30
DELISTED
DZS Inc. Common Stock
DZSI
$6.22M 0.28%
956,258
EXEL icon
31
Exelixis
EXEL
$9.95B
$5.67M 0.26%
2,207,000
ARQL
32
DELISTED
Arqule Inc
ARQL
$5.65M 0.26%
2,520,316
PRTK
33
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.44M 0.25%
173,892
-2
-0% -$63
ECOM
34
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$5.39M 0.24%
556,692
AGRX
35
DELISTED
Agile Therapeutics, Inc
AGRX
$1.24M 0.06%
67
+2
+3% +$36.9K
NURO
36
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$96K ﹤0.01%
22
FOLD icon
37
Amicus Therapeutics
FOLD
$2.42B
-5,653,029
Closed -$47M
RNA
38
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
-6,480,171
Closed -$122M